Bryn Mawr Capital Management LLC Grows Stock Holdings in Maximus, Inc. (NYSE:MMS)

Bryn Mawr Capital Management LLC grew its holdings in Maximus, Inc. (NYSE:MMS) by 290.3% during the 4th quarter, Holdings Channel reports. The fund owned 8,400 shares of the health services provider’s stock after purchasing an additional 6,248 shares during the period. Bryn Mawr Capital Management LLC’s holdings in Maximus were worth $627,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other large investors have also made changes to their positions in MMS. Geode Capital Management LLC boosted its holdings in Maximus by 1.4% during the third quarter. Geode Capital Management LLC now owns 1,525,159 shares of the health services provider’s stock worth $142,109,000 after buying an additional 21,532 shares in the last quarter. Charles Schwab Investment Management Inc. boosted its holdings in Maximus by 12.4% during the third quarter. Charles Schwab Investment Management Inc. now owns 929,066 shares of the health services provider’s stock worth $86,552,000 after buying an additional 102,350 shares in the last quarter. Allspring Global Investments Holdings LLC boosted its holdings in Maximus by 2.4% during the fourth quarter. Allspring Global Investments Holdings LLC now owns 722,172 shares of the health services provider’s stock worth $54,748,000 after buying an additional 16,772 shares in the last quarter. Reinhart Partners LLC. boosted its holdings in Maximus by 43.5% during the fourth quarter. Reinhart Partners LLC. now owns 551,146 shares of the health services provider’s stock worth $41,143,000 after buying an additional 167,019 shares in the last quarter. Finally, Fort Washington Investment Advisors Inc. OH boosted its holdings in Maximus by 39.1% during the fourth quarter. Fort Washington Investment Advisors Inc. OH now owns 296,476 shares of the health services provider’s stock worth $22,132,000 after buying an additional 83,390 shares in the last quarter. 97.21% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

MMS has been the topic of a number of recent analyst reports. Raymond James raised shares of Maximus from a “market perform” rating to an “outperform” rating and set a $90.00 price target on the stock in a report on Thursday, January 2nd. StockNews.com downgraded shares of Maximus from a “buy” rating to a “hold” rating in a report on Friday, February 14th.

Maximus Stock Performance

NYSE:MMS opened at $65.95 on Friday. The company has a debt-to-equity ratio of 0.82, a quick ratio of 1.72 and a current ratio of 1.72. The company has a fifty day moving average of $73.79 and a two-hundred day moving average of $81.72. The stock has a market capitalization of $3.73 billion, a PE ratio of 14.18 and a beta of 0.72. Maximus, Inc. has a fifty-two week low of $64.53 and a fifty-two week high of $93.97.

Maximus (NYSE:MMS) last posted its quarterly earnings data on Thursday, February 6th. The health services provider reported $1.61 earnings per share for the quarter, topping analysts’ consensus estimates of $1.39 by $0.22. Maximus had a net margin of 5.28% and a return on equity of 21.95%. As a group, research analysts forecast that Maximus, Inc. will post 6.15 earnings per share for the current fiscal year.

Maximus Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, February 28th. Shareholders of record on Saturday, February 15th will be given a dividend of $0.30 per share. This represents a $1.20 dividend on an annualized basis and a yield of 1.82%. The ex-dividend date is Friday, February 14th. Maximus’s dividend payout ratio is presently 25.81%.

Insiders Place Their Bets

In other news, insider Michelle F. Link sold 2,208 shares of the stock in a transaction dated Tuesday, December 3rd. The shares were sold at an average price of $73.83, for a total value of $163,016.64. Following the completion of the sale, the insider now directly owns 6,567 shares in the company, valued at $484,841.61. This represents a 25.16 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, insider Ilene R. Baylinson sold 14,500 shares of the stock in a transaction dated Wednesday, February 19th. The shares were sold at an average price of $68.14, for a total transaction of $988,030.00. Following the completion of the sale, the insider now owns 2,512 shares of the company’s stock, valued at $171,167.68. This trade represents a 85.23 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders purchased 7,063 shares of company stock worth $502,017. Company insiders own 1.60% of the company’s stock.

About Maximus

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.